Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yeo Jin Choi, Yong Won Choi, Jung-woo Chae, Hwi-yeol Yun & Sooyoung Shin. (2021) Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index. Risk Management and Healthcare Policy 14, pages 1855-1867.
Read now
Read now
Pingting Zhong, Miao He, Honghua Yu, Qiaowei Wu, Qingsheng Peng, Manqing Huang, Yunlian Xue & Xiaohong Yang. (2020) A Meta-Analysis of Cardiovascular Events Associated with Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion. Current Eye Research 45:5, pages 615-622.
Read now
Read now
Articles from other publishers (3)
Stefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, Paris Makrantonakis, Nikolaos Kentepozidis, Ioannis Boukovinas, Nikolaos Xenidis, Panagiotis Katsaounis, Alexandros Ardavanis, Nikolaos Ziras, Athina Christopoulou, George Rigas, Kostas Kalbakis, Nikolaos Vardakis, Christos Emmanouilides, Ilias Athanasiadis, Athanassios Anagnostopoulos, Dora Hatzidaki, Efthimios Prinarakis, Foteini Simopoulou, Athanasios Kotsakis & Vassilis Georgoulias. (2022) Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group. Current Oncology 29:2, pages 1237-1251.
Crossref
Crossref
Jianxin Chen, Junhui Wang, Tao Ni, Huijuan He & Qinhong Zheng. (2020) Meta-analysis on the risk of fatal adverse events by bevacizumab, cetuximab, and panitumumab in 31 randomized trials including 25,000 patients with colorectal carcinoma. Medicine 99:25, pages e19908.
Crossref
Crossref
Yanshu Wang, Huanhuan Liu, Defan Yao, Jinning Li, Shuyan Yang, Caiyuan Zhang, Weibo Chen & Dengbin Wang. (2019) 18F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts. Journal of Nanobiotechnology 17:1.
Crossref
Crossref